The stakes are high in a case involving generic drug maker Actavis and the Federal Trade Commission that will soon go before the Supreme Court, the head of a generic drug industry lobbying group said in a conference call with reporters Tuesday.
A coalition of consumer groups on Tuesday joined its collective voice to the number of constituents opposing the Express Scripts-Medco merger in a letter to the Federal Trade Commission, according to a report filed by Reuters.
In the wake of a key Senate subcommittee hearing this month, and on the heels of the collapse of the blockbuster AT&T and T-Mobile merger, four more U.S. lawmakers have joined the growing ranks of consumer groups, members of Congress and employers questioning the proposed mega-merger of pharmacy benefit managers Express Scripts and Medco Health Solutions.
The Federal Trade Commission released a report Tuesday finding that drug companies entered 28 deals that the FTC called anticompetitive and said would increase healthcare costs for consumers and the government.
The issue of patent settlements, their effect on drug prices and availability, and by extension their legality has been around for a long time and will likely remain an issue for years to come. But according to a report released in May by the Federal Trade Commission, the settlements have been on the rise, increasing from 16 in 2009 to 31 in 2010.
The Independent Specialty Pharmacy Coalition is urging the Federal Trade Commission to look into the pending merger between pharmacy benefit managers Express Scripts and Medco Health Solutions, the ISPC said Monday.